Concepedia

Thomas Kaley

TK

Statistics

Publications

65

Citations

14.5K

H-Index

40

Active since

2010

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Massachusetts General Hospital

Dana-Farber Cancer Institute

University of California, San Francisco

Cornell University

Thomas Kaley is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and neuro-oncology.

Publications per year

2010–2025

65

Publications

65

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.4K citations · Full text

Medicine, Cancer Biology, Oncology +14

OncoKB: A Precision Oncology Knowledge Base

Debyani Chakravarty, Jianjiong Gao, Sarah Phillips et al. · JCO Precision Oncology · 2017 · 2.7K citations

Medicine, Biomedical Informatics, Oncology +17

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla et al. · Nature Medicine · 2019 · 1.4K citations

Medicine, Immunology, Oncology +17

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia et al. · Journal of the National Comprehensive Cancer Network · 2020 · 564 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

Christian Grommes, Alessandro Pastore, Nicolaos Palaskas et al. · Cancer Discovery · 2017 · 402 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 65